Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-23

Clinical Trial Update: Nailfold Capillary Blood Flow With Latanoprost Bunod [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating nailfold capillary blood flow with latanoprost bunod in open-angle glaucoma has completed; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • latanoprost bunod (latanoprost bunod)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Glaucoma, Open-Angle | Phase 4 | Status: COMPLETED | Results posted: 2021-08-23